Alamar Biosciences Inc Cl A (ALMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||
| Net Income | -21,325 | N/A | -7,659 |
| Depreciation Amortization | 1,234 | N/A | 722 |
| Accounts receivable | -6,854 | N/A | -533 |
| Accounts payable and accrued liabilities | 1,339 | N/A | 578 |
| Other Working Capital | -11,388 | N/A | -7,062 |
| Other Operating Activity | 16,647 | 0 | 886 |
| Operating Cash Flow | $-20,347 | $N/A | $-13,068 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | N/A | N/A | 18,000 |
| PPE Investments | -600 | N/A | -554 |
| Other Investing Activity | -178 | 0 | -428 |
| Investing Cash Flow | $-778 | $N/A | $17,018 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 1,803 | N/A | 243 |
| Other Financing Activity | 53,958 | 0 | 0 |
| Financing Cash Flow | $55,761 | $N/A | $243 |
| Exchange Rate Effect | -52 | N/A | 133 |
| Beginning Cash Position | 34,909 | N/A | 31,677 |
| End Cash Position | 69,493 | N/A | 36,003 |
| Net Cash Flow | $34,584 | $N/A | $4,326 |
| Free Cash Flow | |||
| Operating Cash Flow | -20,347 | N/A | -13,068 |
| Capital Expenditure | -600 | N/A | -554 |
| Free Cash Flow | -20,947 | 0 | -13,622 |